4d Molecular Therapeutics In shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in 4d Molecular Therapeutics In by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $478k | 24k | 20.26 |
| 2023-09-30 | $300k | 24k | 12.73 |
| 2023-06-30 | $175k | 10k | 17.19 |
| 2023-03-31 | $175k | 10k | 17.19 |
| 2022-09-30 | $216k | 27k | 8.04 |
| 2022-06-30 | $92k | 13k | 6.98 |
| 2022-03-31 | $199k | 13k | 15.12 |
| 2021-12-31 | $289k | 13k | 21.94 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas